Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fidler

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
AIDS and Behavior|July 24, 2021
Uptake of HIV Testing Services Through Novel Community-Based Sexual and Reproductive Health Services: An Analysis of the Pilot Implementation Phase of the Yathu Yathu Intervention for Adolescents and Young People Aged 15-24 in Lusaka, ZambiaB Hensen, M Phiri, A Schaap, et al.
Contemporary Clinical Trials|September 20, 2021
Yathu Yathu ("For us, by us"): Design of a cluster-randomised trial of the impact of community-based, peer-led comprehensive sexual and reproductive health services for adolescents and young people aged 15 to 24 in Lusaka, ZambiaB Hensen, M Phiri, A Schaap, et al.
HIV Medicine|May 8, 2021
Tolerability of four-drug antiretroviral combination therapy in primary HIV-1 infectionJ E Burns, W Stöhr, S Kinloch-De Loes, et al.
Immunology Letters|October 12, 2001
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?S L Rowland-Jones, S Pinheiro, R Kaul, et al.
HIV Medicine|April 10, 2019
Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South AfricaP Bock, K Nel, G Fatti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 24, 2000
Neurocan is upregulated in injured brain and in cytokine-treated astrocytesR A Asher, D A Morgenstern, P S Fidler, et al.
BMC Public Health|December 13, 2022
Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan AfricaK Sabapathy, L Balzer, J Larmarange, et al.
Scientific Reports|January 11, 2022
Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological reboundP Zacharopoulou, E Marchi, A Ogbe, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 12, 1999
Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2P S Fidler, K Schuette, R A Asher, et al.
Plos Medicine|May 31, 2024
Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trialL Telisinghe, S Floyd, D MacLeod, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
AIDS and Behavior|July 24, 2021
Uptake of HIV Testing Services Through Novel Community-Based Sexual and Reproductive Health Services: An Analysis of the Pilot Implementation Phase of the Yathu Yathu Intervention for Adolescents and Young People Aged 15-24 in Lusaka, ZambiaB Hensen, M Phiri, A Schaap, et al.
Contemporary Clinical Trials|September 20, 2021
Yathu Yathu ("For us, by us"): Design of a cluster-randomised trial of the impact of community-based, peer-led comprehensive sexual and reproductive health services for adolescents and young people aged 15 to 24 in Lusaka, ZambiaB Hensen, M Phiri, A Schaap, et al.
HIV Medicine|May 8, 2021
Tolerability of four-drug antiretroviral combination therapy in primary HIV-1 infectionJ E Burns, W Stöhr, S Kinloch-De Loes, et al.
Immunology Letters|October 12, 2001
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?S L Rowland-Jones, S Pinheiro, R Kaul, et al.
HIV Medicine|April 10, 2019
Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South AfricaP Bock, K Nel, G Fatti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 24, 2000
Neurocan is upregulated in injured brain and in cytokine-treated astrocytesR A Asher, D A Morgenstern, P S Fidler, et al.
BMC Public Health|December 13, 2022
Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan AfricaK Sabapathy, L Balzer, J Larmarange, et al.
Scientific Reports|January 11, 2022
Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological reboundP Zacharopoulou, E Marchi, A Ogbe, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 12, 1999
Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2P S Fidler, K Schuette, R A Asher, et al.
Plos Medicine|May 31, 2024
Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trialL Telisinghe, S Floyd, D MacLeod, et al.
Pageof 8